-
-
-
-
-
-
-
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance
-
-
-
-
-
-
-
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
-
-
-
-
-
-
-
LivaNova Reports Second-Quarter 2023 Results
-
-
-
-
-
-
-
LivaNova plc (LIVN) Comments on Court of Appeal of Milan's EUR 453M Decision
-
-
-
-
-
-
-
LivaNova plc (LIVN) Prices 3.6M Share Offering at $82.5/sh
-
-
-
-
-
-
-
LivaNova (LIVN) Completes Initial Closing of Heart Valve Business to Gyrus Capital
-
-
-
-
-
-
-
Stacy Enxing Seng Joins the Vesper Medical Board of Directors
-
1,178,831 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

